Sigma-Tau Pharmaceuticals, Inc. Changes Name to Leadiant Biosciences, Inc. and Reaffirms its Commitment to Rare Disease Communities

By | Uncategorized | No Comments

Gaithersburg, MD, (February 28, 2017) – Sigma-Tau Pharmaceuticals, Inc., a leader in the development and commercialization of medicines for patients with rare diseases, today announced that the company has changed its name to Leadiant Biosciences, Inc. reaffirming the company’s continued strong commitment to the patient communities it serves.

Read More